What is the main business of Apteka 36,6?

The main business activity of Apteka 36,6 focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 7, 2005.

Where is the headquarters located?

The headquarters is located at: Aleje Jerozolimskie 134, 02-305 Warszawa.

What is the share capital?

The share capital of the company is PLN 1,300,000 (approx. $351,162).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $5,657,428 in 2025, which is an increase of 16.6% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $225,888 in 2025, meaning the company increased its profit by 6.8%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $4,284,443 in 2025, representing 80% of all operating expenses.

Apteka 36,6sp. z o.o.

Q: Who is on the management board?

The management board consists of: Rafał Emil Jarząbek (Vice President of the Management Board), Igor Wojciech Jachorski (President of the Management Board), and Paulina Świderek (Vice President of the Management Board).

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2005-04-07

Share capital

1 300 000,00 PLN

Registered address

Aleje Jerozolimskie 134, 02-305 Warszawa, Poland

Electronic delivery address

AE:PL-53190-94851-DUHCF-34

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 5.66mMedianUSD 1.76mAverageUSD 4.96m

Net profit

This companyUSD 225.89kMedianUSD 17.49kAverageUSD 77.31k

Operating costs

This companyUSD 5.35mMedianUSD 1.72mAverageUSD 4.80m

Assets

This companyUSD 1.83mMedianUSD 495.60kAverageUSD 1.69m

Industry

Bank accounts

Registered as a VAT taxpayer on 2005-04-21. Active

BNP Paribas Bank Polska
49 1750 0009 0000 0000 2361 4057
BNP Paribas Bank Polska
95 1600 1462 1085 4737 2000 0003

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,297$3,297	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,999$3,999	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,937$3,937	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Authorized Representatives

Rafał Emil Jarząbek — Vice President of the Management Board

Igor Wojciech Jachorski — President of the Management Board

Paulina Świderek — Vice President of the Management Board

Manner of representation

The management board consists of at least two members. Where a multi-member management board is appointed, two members of the management board acting jointly, or one member of the management board acting together with a commercial proxy, are authorised to make declarations of will on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Apteka Polonez sp. z o.o.	2,600	$351,161.53	100%

Beneficial owners

Person	Rights
Zbigniew Jacek Molenda (63)	„sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki”.
Jacek Romuald Szwajcowski (62)	„sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki”.

Competitors

Name	Revenue	Website
Cosmedicasp. z o.o.	$49,355,260.75	cosmedica.pl
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
MagmaxS.A.	$4,200,912.15	magmaxsa.pl
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com

Change history

Date	Event
2022-07-08	PKD change (Removed: 46.17.Z, 73.11.Z, 96.04.Z; Added: 10.86.Z, 10.89.Z, 21.10.Z)
2021-12-15	Address change (Żytnia 15/17, 01-014, Warszawa → Aleje Jerozolimskie 134, 02-305, Warszawa)
2019-03-13	Share capital change (1,200,000.00 PLN → 1,300,000.00 PLN)
2015-05-18	PKD change (Removed: 21.10.Z, 46.15.Z, 46.16.Z, 46.19.Z, 46.45.Z, 46.46.Z, 46.66.Z, 46.75.Z, 46.90.Z, 47, 52.10.B, 52.24.C, 62.02.Z, 68.10.Z, 70.22.Z, 71.12.Z, 73.20.Z, 82.30.Z, 82.92.Z, 96.09.Z; Added: 47.73.Z)
2009-12-23	PKD change (Removed: 24.41.Z, 24.42.Z, 51, 51.15.Z, 51.16.Z, 51.17.Z, 51.19.Z, 51.45.Z, 51.46.Z, 51.55.Z, 52.12.Z, 52.27.B, 52.31.Z, 52.32.Z, 52.33.Z, 52.48.B, 63, 70.12.Z, 70.20.Z, 72.10.Z, 74, 74.13.Z, 74.14.A, 74.40.Z, 74.82.Z, 74.87.A, 93.04.Z, 93.05.Z; Added: 21.10.Z, 21.20.Z, 46.15.Z, 46.16.Z, 46.17.Z, 46.19.Z, 46.45.Z, 46.46.Z, 46.66.Z, 46.75.Z, 46.90.Z, 47, 47.19.Z, 47.29.Z, 47.74.Z, 47.75.Z, 52.10.B, 52.24.C, 62.02.Z, 68.10.Z, 68.20.Z, 70.22.Z, 71.12.Z, 73.11.Z, 73.20.Z, 82.30.Z, 82.92.Z, 96.04.Z, 96.09.Z)

FAQ

Last updated: 2026-05-24